Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and resistance to the standard treatment (chloroquine) is now high in some …

Background Plasmodium vivax is an important cause of malaria in many parts of Asia and
South America, and parasite resistance to the standard treatment (chloroquine) is now high …

Background Artemisinin-based combination therapy (ACT) is recommended for
uncomplicated Plasmodium vivax malaria in areas of emerging chloroquine resistance. We …

Background This study aimed to synthesize available evidence on the efficacy of
dihydroartemisinin-piperaquine (DHP) in treating uncomplicated Plasmodium vivax malaria …

Abstract Background The World Health Organization (WHO) recommends artemisinin‐
based combination therapy (ACT) for treating people with Plasmodium falciparum malaria …

Background Artemisinin‐based combination treatments are strongly advocated, but supplies
are limited. Sulfadoxine combined with amodiaquine is an alternative non‐artemisinin …

Background The World Health Organization recommends uncomplicated P. falciparum
malaria is treated using Artemisinin‐based Combination Therapy (ACT). This review aims to …

Background The World Health Organization (WHO) recommends artemisinin‐based
combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria …

Background There is general international agreement that the importance of vivax malaria
has been neglected, and there is a need for new treatment approaches in an effort to …

Background The World Health Organization (WHO) recommends that people with
uncomplicated Plasmodium falciparum malaria are treated using Artemisinin‐based …